Managed Care

Managing Editor’s Memo
Frank Diamond
Ezekiel J. Emanuel, MD, and Andy Slavitt will not let the ACA go gentle into that good night, and their arguments make for engaging reading in this print-free, all-Q&A edition of Managed Care (as usual, we’ve edited the transcripts for clarity and length). Print-free doesn’t mean no footprint,…
Innovation ’19: Survey
Editors

We have identified 11 technologies and financial arrangements that may affect American health care.  Please indicate which category you believe most accurately describes their future over the next 2–5 years.

Follow this link to take the survey.

Letter to the Editor
I read with great anticipation the Viewpoint in the June 2019 issue of Managed Care titled “U.S. Infant and Maternal Mortality Rates: Shamefully (and Unnecessarily) Bad and Getting Worse.” The author, François de Brantes, offered three suggestions: make participation mandatory for seven states…
Editor’s Memo
Peter Wehrwein
Innovation. Hear it and hype-detecting alarm bells go off. Something like a fight-or-flight response kicks in. I can feel my cortisol levels rising. Why? Because innovation is what countless PR and sales pitches are hawking. Many fall into that huge gully between what they promise and what they actually…
Editor’s Memo
Peter Wehrwein
The first time I encountered cost-effectiveness research was during a stint at the Harvard School of Public Health in the early ’90s (the injection of T.H. Chan into the school’s name came much later). I was a journalism fellow there and then worked as a writer and editor. The details have slid…
Managing Editor’s Memo
Frank Diamond
We focus this month on health care’s hidden costs … and also on oncology. There’s a connection because there’s always something new, and usually costly, in oncology. On April 4, the FDA said that Pfizer’s Ibrance (palbociclib) can be used to treat breast cancer in men. Each year in the…
Editor’s Memo
Peter Wehrwein
It has been a long time since Doug Ross, Mark Greene, Carol Hathaway, and the demanding Peter Benton were saving lives every week on our television screens (Carter, too, although he was often fumbling at the beginning). For some of us, though, it’s difficult not to think about the images and associations…
News & Commentary
Cigna’s CEO David Cordani may be stepping in front of Aetna CEO Mark Bertolini as the most quotable and charismatic leader of a health insurance plan. He’s been Q&A’d a lot since Cigna’s purchase of Express Scripts late last year. Here is what he said to the Associated Press: “Figuring…

A blueprint for high-volume, high-quality lung cancer screening that is detecting cancer earlier—and helping to save lives

Clinical Brief

Multiple Sclerosis: New Perspectives on the Patient Journey–2019 Update
Summary of an Actuarial Analysis and Report